MK-0431

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0431, covering 2017-04-04 to 2017-04-04. Get the full timeline:

Most recent: Clinical Trial Update: MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043) [Phase 2]